Janssen Alzheimer's Patent Not Valid: Fed. Circ.
A federal appeals court has upheld a decision that invalidated Janssen Pharmaceutica NV's patent covering a method for treating Alzheimer's disease, handing a victory to a group of generic-drug companies accused...To view the full article, register now.
Already a subscriber? Click here to view full article